Philadelphia-based Rothman Orthopaedics is looking for its third CEO within four years, it shared with Becker's in a Dec. 16 press release.
Ed Tufaro, who is leaving to pursue an undisclosed career opportunity, was named interim CEO in March 2023 after previously serving as the practice's senior vice president of operations. He has worked with the organization since 2018.
He was appointed interim CEO following the exit of former CEO Christopher Olivia, MD. Mr. Tufaro had "interim" removed from his title in August 2023.
Dr. Olivia is currently involved in litigation with Rothman over his dismissal. He succeeded Rothman CEO Mike West.
Chris Higgins, who is CFO at Rothman, will take over as interim CEO. Mr. Tufaro transitioned into a consultant role effective Dec. 10, and will soon be departing from the organization entirely.
Mr. Tufaro "has been instrumental in fostering innovation, enhancing patient-centered care, and driving [patient care] growth, solidifying Rothman’s position as a leader in orthopedics."
Alexander Vaccaro, MD, president of Rothman Orthopaedics, and Gerald Williams Jr., MD, the group’s board chairperson, said in the release. He "successfully navigated post-pandemic challenges faced by many private practices, achieving a strong rebound in 2024."
"Rothman’s Board of Directors has initiated a search for a new CEO, and is confident in securing top-tier leadership in keeping with Rothman Orthopaedics’ long standing legacy," the release said. "We extend our deepest gratitude to Ed for his outstanding leadership and contributions, and we wish him and his family every success in this exciting new chapter."